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Neuronal lossThe lateral–posterior thalamic nuclei (LP) have been shown to play an important role in controlling epileptic
activity. In addition, thalamic atrophy and neuronal loss have been observed in epilepsy. The objective of this
study was to investigate whether lateral–posterior neuronal activation may be observed shortly after a single
generalized seizure in rats submitted to the pilocarpine model of epilepsy. The results showed an increased
lateral–posterior activation as soon as the seizure occurred, suggesting that neuronal loss in the thalamus
is not only the consequence of chronic epilepsy.
© 2013 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Epilepsy is the most common serious neurological condition, and
its relationship with speciﬁc cerebral structures is crucial, particularly
the thalamic complex. As evidence for this, an experimental study in-
vestigating the interictal cerebral metabolic rate by 14C-2DG autora-
diography in a chronic model of epilepsy clearly demonstrated an
increase in glucose utilization by several brain regions [1]. The most
relevant ﬁnding was a consistent rise of the metabolic rate in the
lateral–posterior thalamic nuclei (LP), suggesting that the LP may be
involved in the cerebral circuitry controlling epileptic activity during
interictal intervals [1]. Then, the contribution and the participation of
LP on spontaneous recurrent seizure (SRS) activity in the same epi-
lepsy model were demonstrated [2]. Brieﬂy, it was shown that bilat-
eral lateral–posterior lesions by ibotenic acid in rats with epilepsy
resulted in a ﬁve-time increase in seizure frequency, suggesting that
the lateral–posterior thalamic nucleus is one of the most important
thalamic nuclei involved in the inhibition of spreading mechanisms
[2]. Along these lines, these data clearly demonstrate the possible
role of the LP in the inhibitory control of excessive activation during
a seizure. Following this line of reasoning, it is pertinent to think
that the integrity of this nucleus may be critical for decreasing the
probability of sudden unexpected death in epilepsy (SUDEP)o Leal Prado, Vila Clementino,
x: +55 11 5573 9304.
da).
vier OA license.occurrence, since high seizure frequency is one of the main risk fac-
tors for SUDEP [3].
The lateral–posterior nucleus is important not only for the regula-
tion of brain hyperexcitation but also for the control of cardiac auto-
nomic function. The thalamus receives inputs from the insular
cortex and amygdala, which are interconnected with each other and
with autonomic nuclei of the brain stem and spinal cord. Additionally,
its projections to the hypothalamus, periaqueductal gray, and nucleus
ambiguus give rise to parallel pathways that inﬂuence both parasym-
pathetic and sympathetic outﬂows associated with cardiac and respi-
ratory control [4]. Previous ﬁndings in the literature have associated
abnormal activity of thalamic nuclei with nocturnal apneic episodes
[5] as well as with cardiac arrhythmias [6] and altered heart rate
variability [7]. Recent studies performed in our laboratory have
found transient alterations in heart rate and heart rate variability
(such as decreased RR intervals, SDNN, and RMSSD) in LP-injured
rats free from epilepsy [8]. Animals submitted to the pilocarpine
model of epilepsy also showed decreased RR intervals, and RMSSD
and increased LF% [8]. It has been recognized that seizures can be asso-
ciated with heart rate changes and ECG abnormalities [9], and cardiac
arrhythmias associated with respiratory changes may also be an im-
portant cause or factor for the occurrence of SUDEP [10]. In our previ-
ous study [8], morphological analyses of the lateral–posterior nucleus
in rats with epilepsy were also undertaken and showed a 62.05%
reduction in the immunohistochemistry for Neu-N (100% being the
staining quantiﬁed in the control group). There were no signiﬁcant
differences for Nissl staining, although qualitative differences in the
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ilepsy and the control group [8].
However, a question that has not yet been addressed is whether
alterations in the lateral–posterior nucleus may be observed in the
early stages of epileptogenesis (e.g., after the ﬁrst seizure) or whether
lateral–posterior abnormalities require longer periods to be observed
(e.g., after the occurrence of many seizures). Therefore, the objective
of the present study was to investigate whether the lateral–posterior
neuronal activation may be observed shortly after a single general-
ized tonic–clonic seizure in rats submitted to the pilocarpine model
of epilepsy.
2. Methods
Adult male Wistar rats (n = 15) were divided randomly into
three groups. The ﬁrst group was composed of rats that received
pilocarpine (n = 05). Status epilepticus (SE) was induced according
to the procedure described previously [11,12]. In brief, 30 min after
methylscopolamine injection (1 mg/kg sc, Sigma, USA, used to reduce
the peripheral effects of pilocarpine), pilocarpine (450 mg/kg ip,
Sigma, USA) was administered to rats. Only rats that displayed a
tonic–clonic seizure (classiﬁed according to the Racine's seizure
index [13]) were included in this study and perfused as soon as this
tonic–clonic seizure occurred. The second group was composed of
rats that were placed in CO2 chamber and then perfused as soon as
unconscious (n = 05). This group is extremely important because
the lateral–posterior nucleus can be activated because of apnea asso-
ciated with a seizure, and hence, this group controls for the apnea fac-
tor. The third group was composed of control rats. These rats were
injected with saline solution and perfused after 30 min (n = 05).
After the perfusion process, the brains were ﬁxed, sliced 40 μm in
vibratome (Leica®), and processed for c-Fos immunohistochemistry.
The procedures involving the animals and their care at theFig. 1. Representative digital images (coronal sections) of c-Fos immunolabeled neurons in
chamber (middle panels), and pilocarpine (bottom panels) groups. Note the increased c-Fo
as compared with the control and CO2 chamber groups.Experimental Neurology Laboratory of the Federal University of São
Paulo (CEP Protocol 0401/11) conformed with the institution's guide-
lines, which comply with the International Ethical Guidelines for Bio-
medical Research [14].
A Nikon E600FN microscope equipped with a digital camera was
used for image digitalization. Quantiﬁcation of c-fos immunolabeled
cells was performed using the ImageJ software (National Institutes
of Health, Bethesda, MD, USA) by an individual blinded to the treat-
ments. Following background subtraction, the threshold was deter-
mined so that all labeled nuclei could be recognized. Quantitative
analysis was performed on three sections from every animal (the
mean count for each animal was used in the statistical analysis).
The appropriate areas were identiﬁed according to the atlas of
Paxinos and Watson [15]. Cell densities were obtained by dividing
the total number of positive cell nuclei by the area of the region
examined at 20× magniﬁcation. The amount of c-fos immunolabeled
cells (expressed as the average number of cells per mm2) was com-
pared between groups by means of a Kruskal–Wallis one-way analysis
of variance (with a Mann Whitney U test for individual comparisons).
3. Results
Fig. 1 shows representative images of c-Fos expression from con-
trol, CO2 chamber, and experimental rats. Qualitative analysis in
c-Fos expression showed that the lateral–posterior nucleus is not
active in the control condition. On the other hand, the generalized sei-
zure induced by pilocarpine injection activated the lateral–posterior
nucleus after a few minutes from the tonic–clonic seizure initiation.
The apnea caused by the CO2 chamber did not induce increased
activation in this nucleus, indicating that the activation of lateral–
posterior neurons was caused by the seizure per se (see the
Discussion section for details). Fig. 2 shows box plots representing
the quantiﬁcation of c-fos expression for each group. The Kruskal–the lateral–posterior nucleus of the thalamus (LP) for the control (upper panels), CO2
s expression for the experimental group (pilocarpine-induced seizure, bottom images)
Fig. 2. Density of c-fos immunolabeled neurons in the lateral–posterior nucleus of
the thalamus. Box plots for the pilocarpine, control, and CO2 chamber groups are
shown from left to right. Horizontal lines in the box plots represent the median,
upper, and lower quartiles; the whiskers plot the range. Asterisk (*) denotes signiﬁcant
differences (P b 0.05) between groups. n.s. = not signiﬁcant.
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(H(2) = 9.5, P = 0.0087). Pairwise comparisons (Mann Whitney U
tests) showed higher density of c-fos immunolabeled cells for the pilo-
carpine group as compared with the control (P = 0.009) and the CO2
chamber (P = 0.009) group. No signiﬁcant differences were found be-
tween the control and CO2 chamber groups (P = 0.602).
4. Discussion
Besides its role in controlling heart rate and heart rate variability,
the lateral–posterior nucleus is very important because of the variety
of ways it controls the spread of limbic seizures [1] and because of its
crucial role in the initiation and/or generalization of cerebral circuitry
involved with controlling spontaneous recurrent seizures [2]. The
present research adds to the current knowledge by showing that the
increased lateral–posterior activation is observed shortly after the ﬁrst
seizure in the life of the animal. The use of the CO2 chamber group
was very important to control for the possible effect of apnea (associat-
ed with seizure) in increasing the activation of the LP. In average, the
time it took for the animals administered with CO2 to be rendered un-
conscious was approximately 2 min, which is longer than the seizure
period of the pilocarpine animals (i.e., the pilocarpine animals were
perfused as soon as the tonic–clonic seizure occurred). Therefore, the
increased c-fos expression observed in the pilocarpine group (with no
changes in c-fos expression for the CO2 chamber group) indicates that
the increased lateral–posterior activation was not due to apnea but
probably due to a mechanism inherent to the seizure per se.
In epileptic seizures, the thalamus undergoes permanent changes
while participating in seizure generalization. Furthermore, thalamic
atrophy and neuronal loss have been observed in animal models of
temporal lobe epilepsy [16]. Patients who died after SE presented
neuronal loss in the thalamus ipsilateral to the seizure focus
[17]. In the present study, we found increased activation of the later-
al–posterior nucleus as soon as the ﬁrst seizure occurred, suggesting
that thalamic damage may be present at the early stages of
epileptogenesis, which may contribute to trigger the mechanisms
responsible for chronic epilepsy and SUDEP. However, we still do not
know whether this increased activation is reversible or whether it
can become more robust and irreversible with the persistence of
chronic epilepsy.Neuronal activation in the lateral–posterior nucleus can lead to al-
terations in the cardiovascular autonomic nervous system andmay be
a risk factor for the occurrence of SUDEP. Therefore, we should focus
on the importance of the integrity of the thalamic complex in epilep-
sy, especially the lateral–posterior nucleus, due to its function on SRS
initiation and/or generalization and its relationship with heart rate
and heart rate variability [8].
The increased activation of the LP observed by c-Fos immunohis-
tochemistry in this study suggests that high levels of excitation may
trigger an excitotoxicity mechanism, thereby leading to neuronal
death and decreased thalamic volume. Decreased thalamic volume
is usually observed in both cerebral sides [18,19] and is not related
to epilepsy duration because abnormal thalamic volume was also ob-
served in children newly diagnosed with epilepsy [20,21]. Therefore,
the mechanisms behind neuronal death and decreased volume in the
thalamus must be further investigated so as to provide the scientiﬁc
basis for the development of therapeutic interventions for preventing
SRSs and SUDEP. Mapping the levels of thalamic activation through dif-
ferent stages of epilepsy models is the ﬁrst step, and requires further
studies.
Another interesting question to be investigated is the potential
use of deep brain stimulation in the LP. For instance, electrical stimu-
lation of the anterior nucleus of the thalamus has been shown to
be effective in the treatment of patients with drug-refractory partial
and secondarily generalized seizures [22]. However, clinical evidence
has proceeded with only limited understanding of the basic mecha-
nisms of brain stimulation, and research studies with animal models
often lead to contradictory results, with some pointing to antiseizure
effects [23], while others suggest no effect [24] or even a proseizure
effect [25]. Such contradictory outcomes are likely associated with de-
tails in stimulation parameters, sites of stimulation, and other unknown
factors [26]. The acute lateral–posterior activation found in the present
study highlights the important role of the lateral–posterior thalamic
nucleus in controlling the spread of limbic and recurrent seizures
and its potential association with the mechanisms underlying SUDEP.
Therefore, future investigations on the use of LP deep brain stimulation
to control seizures and prevent SUDEP should be considered.
We can conclude that the neuronal loss in the thalamus may not
be only the consequence of chronic epilepsy as we observed that neu-
ronal activation may also occur shortly after the ﬁrst and only gener-
alized seizure. This neuronal activation is probably a consequence of
an attempt to control the seizure. However, hyperexcitability
may lead to vicious circle: the more neurons are activated, the more
neurons die, and other healthy neurons are activated. Therefore, it
is suggested that thalamic damage may begin at the early stages
of epileptogenesis, which may contribute to trigger the mecha-
nisms responsible for chronic epilepsy and SUDEP. The probable
mechanisms of thalamic activation that can lead to neuronal death in
epilepsy should be investigated.
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